Patents by Inventor Sergio COVARRUBIAS

Sergio COVARRUBIAS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treating inflammatory diseases
    Patent number: 11505798
    Abstract: The disclosure is directed to inhibitory agents that hybridize to a GAPLINC RNA and inhibit or reduce the expression of the GAPLINC RNA. The GAPLINC RNA is a long non-coding RNA (lncRNA) located on chromosome 18 between the protein-coding genes Tgif and Dlgap1. The disclosure also features pharmaceutical compositions including the inhibitory agents and methods of using the inhibitory agents to treat an inflammatory disease, such as sepsis.
    Type: Grant
    Filed: September 23, 2020
    Date of Patent: November 22, 2022
    Assignee: The Regents of the University of California
    Inventors: Susan Carpenter, Apple Vollmers, Sergio Covarrubias
  • METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES
    Publication number: 20210087563
    Abstract: The disclosure is directed to inhibitory agents that hybridize to a GAPLINC RNA and inhibit or reduce the expression of the GAPLINC RNA. The GAPLINC RNA is a long non-coding RNA (lncRNA) located on chromosome 18 between the protein-coding genes Tgif and Dlgap1. The disclosure also features pharmaceutical compositions including the inhibitory agents and methods of using the inhibitory agents to treat an inflammatory disease, such as sepsis.
    Type: Application
    Filed: September 23, 2020
    Publication date: March 25, 2021
    Applicant: The Regents of the University of California
    Inventors: Susan CARPENTER, Apple VOLLMERS, Sergio COVARRUBIAS